Paper41821908
A novel approach to Peyronie's disease: Intralesional injection of lyophilized platelet-derived growth factors.
Abdelrahman IFS and 7 others. Cent European J Urol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. A novel approach to Peyronie's disease: Intralesional injection of lyophilized platelet-derived growth factors. Papers, record 41821908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41821908
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A novel approach to Peyronie's disease: Intralesional injection of lyophilized platelet-derived growth factors.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33754800 | Using intra-articular allogenic lyophilized growth factors in primary knee osteoarthritis: a randomized pilot study. | Regen Med | 2021 | https://conductscience.org/library/papers/33754800 | PubMed |
| 2 | 28874327 | Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease-A Review of the Literature and a New Modified Protocol. | Sex Med Rev | 2017 | https://conductscience.org/library/papers/28874327 | PubMed |
| 3 | 29761688 | Collagenase clostridium histolyticum: a novel medical treatment for Peyronie's disease. | Minerva Urol Nefrol | 2018 | https://conductscience.org/library/papers/29761688 | PubMed |
| 4 | 26516079 | Growth Factor Release from Lyophilized Porcine Platelet-Rich Plasma: Quantitative Analysis and Implications for Clinical Applications. | Aesthetic Plast Surg | 2016 | https://conductscience.org/library/papers/26516079 | PubMed |
| 5 | 28612401 | Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol. | BJU Int | 2017 | https://conductscience.org/library/papers/28612401 | PubMed |
| 6 | 22739749 | Advances in understanding of mammalian penile evolution, human penile anatomy and human erection physiology: clinical implications for physicians and surgeons. | Med Sci Monit | 2012 | https://conductscience.org/library/papers/22739749 | PubMed |
| 7 | 17888069 | Validation of the erection hardness score. | J Sex Med | 2007 | https://conductscience.org/library/papers/17888069 | PubMed |
| 8 | 25722595 | Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective. | J Cutan Aesthet Surg | 2014 | https://conductscience.org/library/papers/25722595 | PubMed |
| 9 | 40340108 | European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Hypogonadism, Erectile Dysfunction, Premature Ejaculation, and Peyronie's Disease. | Eur Urol | 2025 | https://conductscience.org/library/papers/40340108 | PubMed |
| 10 | 17287870 | The medical management of Peyronie's disease. | Nat Clin Pract Urol | 2007 | https://conductscience.org/library/papers/17287870 | PubMed |
| 11 | 33813465 | NON-SURGICAL TREATMENT OF PEYRONIE'S DISEASE: A COMPREHENSIVE REVIEW. | Wiad Lek | 2021 | https://conductscience.org/library/papers/33813465 | PubMed |
| 12 | 25664497 | Responsiveness of the Peyronie's Disease Questionnaire (PDQ). | J Sex Med | 2015 | https://conductscience.org/library/papers/25664497 | PubMed |
| 13 | 36721157 | Effectiveness of lyophilized growth factors injection for subacromial impingement syndrome: a prospective randomized double-blind placebo-controlled study. | J Orthop Surg Res | 2023 | https://conductscience.org/library/papers/36721157 | PubMed |
| 14 | 26984291 | Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie's Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study. | Sex Med | 2016 | https://conductscience.org/library/papers/26984291 | PubMed |
| 15 | 28386796 | Management of Peyronie's disease - a review. | World J Urol | 2001 | https://conductscience.org/library/papers/28386796 | PubMed |
| 16 | 30317233 | The Effect of Platelet-Rich Plasma on Peyronie's Disease in Rat Model. | Urol Int | 2019 | https://conductscience.org/library/papers/30317233 | PubMed |
| 17 | 29333517 | Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions. | Investig Clin Urol | 2018 | https://conductscience.org/library/papers/29333517 | PubMed |
| 18 | 22970798 | Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound. | J Sex Med | 2013 | https://conductscience.org/library/papers/22970798 | PubMed |
| 19 | 28974406 | Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study. | J Sex Med | 2017 | https://conductscience.org/library/papers/28974406 | PubMed |
| 20 | 35778315 | Tolerance and efficacy of platelet-rich plasma injections in Peyronie's disease: Pilot study. | Prog Urol | 2022 | https://conductscience.org/library/papers/35778315 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41821908
GET https://conductscience.org/api/papers/v1/41821908/references?page=2